Global E-cigarette Leader Smoore Faces Competition Challenges

Aug.08.2022
China's largest e-cigarette company, Smoore International, faces competition as other companies receive tobacco production licenses.

The world's largest electronic cigarette company, Smoore International (06969.HK), is facing a challenge.


Recently, it was announced by Smore International that three fully-owned subsidiaries have received the Tobacco Monopoly Administration's Production License for Tobacco Monopoly Enterprises.


In the past two years, as regulations for electronic cigarettes have been gradually issued, the industry is moving towards standardization. Data shows that by 2022, the global electronic cigarette market will exceed $108 billion, attracting many industry giants to enter the market.


On the same day that the above notice was released, BYD Electronic and Jingjia Stock also announced that their subsidiaries had obtained exclusive production licenses. This has intensified the competition faced by SMOORE International.


A journalist from China Yangtze Daily noticed that in 2021, Smoore International held a global market share of 22.8%, exceeding the sum of the second to fifth largest companies, and maintained its position as the world's largest manufacturer of electronic atomization devices.


However, after moving towards standardization, the "age of profiteering" for the electronic cigarette industry will become a thing of the past. In the first half of this year, Smoore International's net profit is expected to decline by 46.0% to 53.8% year-on-year.


The industry is rapidly developing and enterprises are increasingly entering cross-border markets.


As the "Electronic Cigarette Management Measures" and mandatory national standards for electronic cigarettes have been introduced this year, the electronic cigarette industry is facing significant changes and gradually moving towards standardization.


Recently, Smoore International announced that its subsidiary has obtained a license to produce tobacco products. The company expressed confidence in its future development and stated that its overall production and operations will continue as planned. The company also affirmed its commitment to comply with relevant national policies and operate within the confines of the law.


According to data, the global electronic cigarette market size is expected to exceed $108 billion by 2022, with overseas markets sustaining a growth rate of 35%. Currently, there are over 1,500 electronic cigarette manufacturers and brands in China, with over 70% of them focused on exporting products overseas. Last year, Chinese electronic cigarette exports reached ¥138.3 billion, a year-on-year increase of 180%; it is expected that the total export value of electronic cigarettes for the whole year will reach ¥186.7 billion, with a growth rate of 35%.


The electronic cigarette industry is rapidly developing, with many large domestic companies diversifying into it. Manufacturing giants like Luxshare Precision, as well as Jingjia Allocation, Jinlong Machinery & Electronics, Shunhao Allocation, Jincheng Medicine, Boteng Allocation, and Huabao Allocation, have successively obtained production qualifications for electronic cigarettes. According to incomplete statistics, more than 130 enterprises have received compliant certificates as of now.


One notable development in the electronics industry is BYD's entry into the electronic cigarette market. Since 2018, BYD Electronics has been laying the groundwork for its electronic cigarette products, having completed patent layouts for its complete range of vaporization products, investment in automated production lines, and the integration of research and development of new materials, precision moulds, product design and development, as well as intelligent manufacturing capabilities.


Abundant production capacity leads to an increase in market share.


Despite facing increasingly fierce competition, Smurfit Kappa, as the industry leader, currently holds a relatively stable position.


In 2021, SMIC held a global market share of 22.8%, surpassing the combined total of second through fifth place. Furthermore, the company has ample production capacity with a scale of 2.59 billion standard units per year in 2021. The completion of its Jiangmen phases one and two will raise its total production capacity to over five billion standard units per year.


However, with the adjustments to regulations in the e-cigarette industry, the era of "excessive profits" will become a thing of the past. As a result, Smoore International experienced a decline in revenue growth during the first half of this year.


According to its recently released performance forecast, the company is expected to generate revenue of approximately RMB 1.322 billion to RMB 1.554 billion in the first half of the year, representing a year-on-year decrease of about 46.0% to 54.1%. The net profit is estimated to be about RMB 1.375 billion to RMB 1.606 billion, representing a year-on-year decrease of about 46.0% to 53.8%.


Simo International has announced a projected 50% decrease in revenue and net profit, citing reduced income from the Chinese market and a shift in product mix leading to lower gross margins. The company also reported significant increases in research and development expenses, management fees, and sales costs as it seeks to bolster its growth prospects in new areas.


It is worth mentioning that in terms of overseas business, Smoore International's major client under the British and American Tobacco umbrella, Vuse brand, has had three products approved through the Pre-Market Tobacco Product Application (PMTA), validating the company's supply chain capabilities. Additionally, the company's contract-manufactured disposable product Vuse go has been launched in non-US markets in Q2, and there will be a rapid increase in production of disposable products in the second half of the year, leading to an expected acceleration of overseas revenue growth in the latter half of the year.


In addition, Sumore International has increased its investment in research and development, with more than 3,000 patent applications filed to date. In 2021, the company's research and development expenses amounted to 670 million yuan, representing a year-on-year increase of 59.7%.


This article contains excerpts or reprints from third-party sources, which are owned by the original media and authors. If there is any infringement, please contact us for deletion. Any organization or individual that needs to reprint must contact the author and must not reprint directly.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
Japan Tobacco International's Irish business has proposed a €0.25 tax increase on a pack of 20 cigarettes in its pre-Budget 2027 submission, below the €0.50-or-more increases typically imposed in recent Irish budgets. JTI says the proposal could generate around €45 million in additional Exchequer revenue while limiting further movement toward illicit and non-Irish-tax-paid tobacco. Revenue's existing estimate for a comparable €0.25 increase, including pro-rata rises on other tobacco products, is about €18 million for a full year.
JTI
Sep.18 by 2Firsts Perspectives
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana's Alcohol and Tobacco Commission (ATC) ordered tobacco certificate holders in September to remove certain vaping products marketed under Elf Bar, Lost Mary, MR FOG, iJOY and other brands from inventory under the state's foreign-adversary product law. The agency later listed 257 MR FOG products and 77 Lost Mary product entries as lawful for sale. The Lost Mary revision expressly stated that compliance evidence had been received for 20 additional products. 2Firsts compliance expert Kurt said potential filings could include e-liquid and ingredient-origin records, U.S. nicotine-analog supply-chain documentation and FDA premarket application status.
Regulations
Oct.08
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Russia's State Duma Passes Tobacco and Nicotine Ingredient Disclosure Bill, Targeting 2027 End to Trade-Secret Protection for Certain Harmful Ingredient Data
Russia's State Duma Passes Tobacco and Nicotine Ingredient Disclosure Bill, Targeting 2027 End to Trade-Secret Protection for Certain Harmful Ingredient Data
Russia's State Duma passed a government-sponsored amendment on November 11, 2026, by 414 votes to none, seeking to prevent businesses from classifying information on the presence and number of types of certain harmful ingredients in tobacco and nicotine-containing products as trade secrets. The measure covers ingredients capable of increasing nicotine dependence or exhibiting toxic, carcinogenic, mutagenic or reproductive toxicity, including substances that acquire such properties during heating or smoldering. Bill No. 1286415-8 would amend Article 5 of Federal Law No. 98-FZ on Commercial Secrets and is scheduled to take effect on January 1, 2027. The bill has cleared all three readings in the State Duma but has not completed the remaining legislative procedures.
Regulations
Nov.12 by 2Firsts Perspectives
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
China exported $979 million of vape-related products in August 2026, up 3.3% from a year earlier but down 6.4% from July. The UK replaced the U.S. as the main source of growth: UK-bound shipments jumped 51.4% to a 2026 high of $177 million, while exports to the U.S. fell 12.4% to $339 million. Shipments to markets outside the U.S. increased 14.2%, broadening growth beyond the market that had driven July’s rebound.
News
Sep.23 by 2Firsts Perspectives